Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Bergareche

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
NPJ Parkinson'S Disease|January 9, 2024
A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cellsYahaira Naaldijk, Belén Fernández, Rachel Fasiczka, et al.
Acta Neuropathologica|June 14, 2021
R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophilsYing Fan, Raja S Nirujogi, Alicia Garrido, et al.
BMC Neurology|October 21, 2009
Prevalence of dementia and major dementia subtypes in Spanish populations: a reanalysis of dementia prevalence surveys, 1990-2008Jesús de Pedro-Cuesta, Javier Virués-Ortega, Saturio Vega, et al.
Neuro-Degenerative Diseases|September 17, 2015
Parkinson's Disease Case Ascertainment in the EPIC Cohort: The NeuroEPIC4PD StudyValentina Gallo, Carol Brayne, Lars Forsgren, et al.
Parkinsonism & Related Disorders|April 8, 2018
Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patientsMatej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, et al.
Movement Disorders Clinical Practice|October 27, 2018
Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease DurationMatej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 30, 2019
The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic InsightSara Bandres-Ciga, Sarah Ahmed, Marya S Sabir, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
NPJ Parkinson'S Disease|January 9, 2024
A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cellsYahaira Naaldijk, Belén Fernández, Rachel Fasiczka, et al.
Acta Neuropathologica|June 14, 2021
R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophilsYing Fan, Raja S Nirujogi, Alicia Garrido, et al.
BMC Neurology|October 21, 2009
Prevalence of dementia and major dementia subtypes in Spanish populations: a reanalysis of dementia prevalence surveys, 1990-2008Jesús de Pedro-Cuesta, Javier Virués-Ortega, Saturio Vega, et al.
Neuro-Degenerative Diseases|September 17, 2015
Parkinson's Disease Case Ascertainment in the EPIC Cohort: The NeuroEPIC4PD StudyValentina Gallo, Carol Brayne, Lars Forsgren, et al.
Parkinsonism & Related Disorders|April 8, 2018
Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patientsMatej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, et al.
Movement Disorders Clinical Practice|October 27, 2018
Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease DurationMatej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 30, 2019
The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic InsightSara Bandres-Ciga, Sarah Ahmed, Marya S Sabir, et al.
Pageof 5